September 14 - 17, 2017   Chicago Marriott Downtown Magnificent Mile

Registration Information

Online registration for 2017 is now open!
Early discounted rates expire July 31

Advance registration is encouraged, as space and materials are limited. To qualify for the discounted registration fee, the completed form and payment must be received by the Lurie Cancer Center on or before July 31, 2017. The registration fee includes conference tuition, CME credits, printed and digital materials, four breakfasts, refreshment breaks and an evening reception. You must make separate hotel arrangements.

Registrants may check in for the conference on the 7th floor of the Chicago Marriott Downtown Magnificent Mile on Wednesday, September 13 from 6:00 p.m. - 8:00 p.m. or beginning at 8:00 a.m. on Thursday, September 14. Walk-in registrations are also welcome beginning at 8:00 a.m. on Thursday, September 14.

REGISTRATION FEES

Type Discounted
Through July 31
Regular
After July 31
General $525 $625
Fellow/Student/Trainee $275 $375
Nurse/Physician Assistant/Nurse Practitioner $275 $375
Industry Fee $725 $825

ADDITIONAL FEES

Lunch Ticket $25/day, no refunds
Breakout Session Ticket $50/day

Digital Materials

Access to General Session Presentations Available

Registrants will be able to view and/or download general session PowerPoint presentations (with some exceptions) via the Lynn Sage Breast Cancer Symposium website the week before the symposia and view updated presentations during and after the live presentations. To access, you must log onto lynnsagebreastcancer.org as a registered participant at the Symposium. Check your e-mail for instructions.

Payment Information

You may pay your fees by credit card (Visa, Master Card, American Express, Discover, Diner's Club and JCB) or by check. Checks must be received by August 18, 2017 to avoid cancelation of your registration. Further instructions will be provided during registration.

Refund/Cancellation Policy

Registration fees less a $50 administrative handling fee are refundable if a written request is received on or before August 18, 2017. Please include your registration ID number when requesting a refund. No refunds will be granted after August 18, 2017, however you may transfer your registration to a colleague.

Letter of Invitation for VISA

An official Letter of Invitation to obtain a VISA and authorization to attend the Lynn Sage Breast Cancer Symposium will be issued ONLY after the Registration Form and full payment have been received.

Special Assistance

In compliance with the Americans with Disabilities Act, Northwestern University will make all reasonable efforts to accommodate persons with disabilities at this meeting. Additionally, if you have any special dietary restrictions, please notify us prior to the symposium.

Inquiries

To submit requests or request further information contact the Lurie Cancer Center at 312.695.1392 or e-mail us at cancer@northwestern.edu.

Related Links

Robert H. Lurie Comprehensive Cancer Center of Northwestern University
LynnSage.org
Lynn Sage Comprehensive Breast Surgical Center

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Hour Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 21.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

The American Academy of Nurse Practitioners and the American Nurses Credentialing Center accept AMA PRA Category 1 Credits(s)™ from organizations accredited by the ACCME.

Faculty Disclosure

Current guidelines state that participants in CME activities should be made aware of any affiliation of financial interest that may affect the speaker's presentation. Each speaker has been requested to complete a faculty disclosure form. The names of faculty members declaring a relationship or who will be discussing off-label usage will be indicated in the course syllabus. All faculty will be disclosing.

Educational Objectives

  1. Practice current management approaches to high risk benign breast lesions.
  2. Describe factors influencing the choice of initial therapeutic approaches - neoadjuvant chemotherapy, mastectomy, oncoplastic breast conservation in operable breast cancer.
  3. Identify the multidisciplinary challenges and opportunities associated with the use of neoadjuvant chemotherapy in operable breast cancer.
  4. Apply optimal pain management strategies in patients with breast cancer
  5. Employ optimal strategies for overcoming endocrine resistance by incorporating targeted therapies
  6. Cite the clinical and molecular factors that determine the optimal duration of adjuvant endocrine therapy
  7. Utilize optimal surgical and medical interventions in the elderly with breast cancer

Sponsored by

Feinberg School of Medicine

© 2016 Robert H. Lurie Comprehensive Cancer Center